GenSight Biologics Announces a Successful Offering for an Amount Over €9.2 Million May 7, 2024 01:30AM
GenSight Biologics to Present at Upcoming Industry and Investor Conferences Sep 20, 2022 01:30AM
Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ASRS, ESGCT and Several Investor and Industry Meetings in October Oct 4, 2021 01:30AM
Gensight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With Us and European Institutional Investors Oct 22, 2020 12:30AM
GenSight Biologics to Participate in Multiple Upcoming Investor Conferences Oct 9, 2018 01:30AM


Oct 4, 2017 01:30AM GenSight Biologics to Attend Chardan Gene Therapy Conference